OUR STORY

Behavioral Health Innovations, LLC is dedicated to the development and use of evidence-based assessments and interventions to improve services and treatment outcomes for traumatized children and their families

ALAN STEINBERG, PH.D.

ALAN STEINBERG, PH.D.

Chief Science Officer/Co-Founder

Dr. Steinberg is Chief Science Officer of BHI and Associate Director of the UCLA/Duke University National Center for Child Traumatic Stress in the Department of Psychiatry and Biobehavioral Sciences at UCLA. He is a recognized authority in the evaluation of children and adolescents exposed to traumatic stress. He has published over 120 theoretical and empirical articles in the most highly prestigious psychiatric journals and books. He is co-creator of the UCLA PTSD Reaction Index for DSM-5 and oversees evaluation of the measure’s psychometric properties and testing of the measure among a wide range of trauma exposed populations

JIM HUSER

JIM HUSER

Chief Executive Officer/Co-Founder

Jim Huser is a Co-Founder of Behavioral Health Innovations. He is currently Executive Vice President of Operations and Chief Financial Officer for Hathaway-Sycamores, one of the largest non-profit behavioral health services agency in Southern California.
Prior to Hathaway-Sycamores, Jim was a Senior Fellow with Community Partners, following a long career in private industry, where he served in senior management roles, as a Board member and as senior advisor.

ROBERT PYNOOS, M.D., M.P.H.

ROBERT PYNOOS, M.D., M.P.H.

Chief Medical Officer/Co-Founder

Dr. Pynoos is Chief Medical Officer of BHI and Co-Director of the UCLA/Duke University National Center for Child Traumatic Stress in the Department of Psychiatry and Biobehavioral Sciences at UCLA. He is a world renowned authority in the field of child and adolescent traumatic stress. He pioneered the use of developmentally-informed quantitative and qualitative measures of traumatized children and their families for clinical care, research, and public health planning. He is responsible for assuring the developmental appropriateness, clinical utility, and diagnostic precision of all BHI measures